J0652
HCPCSInj, levothyroxine, hikma
Official HCPCS Level II long descriptor
Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
HCPCS Level II code J0652 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, levothyroxine, hikma
Added to HCPCS: 2024-04-01
Nearby codes in J0
- J0636Inj calcitriol per 0.1 mcg
- J0637Caspofungin acetate
- J0638Canakinumab injection
- J0640Leucovorin calcium injection
- J0641Inj levoleucovorin nos 0.5mg
- J0642Injection, khapzory, 0.5 mg
- J0650Inj, levothyroxine nos 10mcg
- J0651Inj, levothyroxine, freskabi
- J0654Inj, liothyronine, 1 mcg
- J0665Inj, bupivacaine, nos, 0.5mg
- J0666Inj, bupivacaine liposome
- J0668Instill, bupivac and meloxic
- J0670Inj mepivacaine hcl/10 ml
- J0675Inj, carboprost, 0.1 mg
- J0681Inj ceftobipole medocarl 3mg
- J0687Inj cefazolin (wg crit care)
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.